Molecular Templates (MTEM) Short Interest Ratio & Short Volume → The Overlooked Retirement Asset You Probably Don’t Own (From Crypto 101 Media) (Ad) Free MTEM Stock Alerts $1.45 -0.05 (-3.33%) (As of 05/17/2024 08:54 PM ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainability Molecular Templates Short Interest DataCurrent Short Volume169,100 sharesPrevious Short Volume205,600 sharesChange Vs. Previous Month-17.75%Dollar Volume Sold Short$277,324.00Short Interest Ratio / Days to Cover2.5Last Record DateApril 30, 2024Outstanding Shares6,580,000 sharesFloat Size3,610,000 sharesShort Percent of Float4.68%Today's Trading Volume21,500 sharesAverage Trading Volume51,778 sharesToday's Volume Vs. Average42% Short Selling Molecular Templates ? Sign up to receive the latest short interest report for Molecular Templates and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatMTEM Short Interest Over TimeMTEM Days to Cover Over TimeMTEM Percentage of Float Shorted Over Time Ad Stansberry Research41 banks launch ‘crypto dollar’Everyone knows the US financial system is in the middle of a radical change... The White House wants an all-digital dollar. Plus at least 41 major banks (see if your bank is one of them right here).Here's how you capitalize (including #1 crypto to play it). Molecular Templates Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/2024169,100 shares $277,324.00 -17.8%4.7%2.5 $1.64 4/15/2024205,600 shares $365,968.00 +508.3%7.0%3.3 $1.78 3/31/202433,800 shares $75,712.00 +23.8%1.2%0.6 $2.24 3/15/202427,300 shares $75,075.00 -29.8%0.6%1.8 $2.75 2/29/202438,900 shares $149,765.00 -31.4%0.9%3.6 $3.85 2/15/202456,700 shares $205,254.00 -9.6%1.3%6.3 $3.62 Get the Latest News and Ratings for MTEM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Molecular Templates and its competitors with MarketBeat's FREE daily newsletter. 1/31/202462,700 shares $220,077.00 +6.3%1.4%6.7 $3.51 1/15/202459,000 shares $212,400.00 -9.0%1.4%6.2 $3.60 12/31/202364,800 shares $241,704.00 +76.1%1.5%6.8 $3.73 12/15/202336,800 shares $134,688.00 -45.1%0.8%4.2 $3.66 11/30/202367,000 shares $326,960.00 -0.5%1.5%8 $4.88 11/15/202367,300 shares $351,306.00 +2.0%1.5%8.4 $5.22 10/31/202366,000 shares $363,000.00 +11.5%1.5%7.3 $5.50 10/15/202359,200 shares $377,790.72 +1.7%1.4%6.1 $6.38 9/30/202358,200 shares $367,824.00 -6.9%1.3%3.8 $6.32 9/15/202362,500 shares $428,750.00 +9.3%1.4%4.2 $6.86 8/31/202357,200 shares $486,772.00 -39.9%1.3%4 $8.51 8/15/202395,100 shares $789,330.00 -88.3%2.2%6.3 $8.30 7/31/2023809,600 shares $486,569.60 -17.5%N/A3.9 $0.60 7/15/2023981,100 shares $483,682.30 +3.8%N/A5.3 $0.49 6/30/2023945,100 shares $453,648.00 -12.5%2.1%8.3 $0.48 6/15/20231,080,000 shares $539,892.00 +1.9%2.4%7 $0.50 5/31/20231,060,000 shares $498,200.00 +1.9%2.3%1.4 $0.47 5/15/20231,040,000 shares $436,800.00 -14.8%2.3%1.4 $0.42 4/30/20231,220,000 shares $479,338.00 -12.9%2.7%1.6 $0.39 4/15/20231,400,000 shares $658,000.00 +40.0%3.1%1.8 $0.47 3/31/20231,000,000 shares $379,900.00 -5.7%2.3%1.3 $0.38 3/15/20231,060,000 shares $349,906.00 +187.2%2.5%1.4 $0.33 2/28/2023369,100 shares $173,477.00 +27.2%0.9%2.7 $0.47 2/15/2023290,200 shares $139,644.24 -15.9%0.7%1.8 $0.48 1/31/2023345,100 shares $186,008.90 +5.5%0.8%2.1 $0.54 1/15/2023327,200 shares $150,577.44 -6.3%0.7%2.1 $0.46 12/30/2022349,000 shares $114,472.00 -17.7%0.8%2.3 $0.33 12/15/2022423,900 shares $190,755.00 -4.4%1.0%3.2 $0.45 11/30/2022443,500 shares $235,010.65 +3.4%1.0%3.6 $0.53 11/15/2022429,100 shares $272,735.96 -19.6%1.0%4.1 $0.64 10/31/2022533,500 shares $316,952.35 +1.0%1.2%5.4 $0.59 10/15/2022528,100 shares $343,159.38 +7.4%1.3%4.8 $0.65 9/30/2022491,800 shares $368,702.46 -6.9%1.2%4.2 $0.75 9/15/2022528,100 shares $417,938.34 +40.1%1.3%2.5 $0.79Crypto Pioneer Says: “The last crypto bull market has begun.” (Ad)Right now, there’s over $6 trillion in potential investment money waiting on the sidelines. That means this crypto bull market has a lot more room to run before it comes close to being a bubble.Click here if you’d like to learn more about these five cryptos… MTEM Short Interest - Frequently Asked Questions What is Molecular Templates' current short interest? Short interest is the volume of Molecular Templates shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 169,100 shares of MTEM short. 4.68% of Molecular Templates' shares are currently sold short. Learn More on Molecular Templates' current short interest. What is a good short interest ratio for Molecular Templates? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MTEM shares currently have a short interest ratio of 2.0. Learn More on Molecular Templates's short interest ratio. What is a good short interest percentage for Molecular Templates? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.68% of Molecular Templates' floating shares are currently sold short. Is Molecular Templates' short interest increasing or decreasing? Molecular Templates saw a decline in short interest during the month of April. As of April 30th, there was short interest totaling 169,100 shares, a decline of 17.8% from the previous total of 205,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Molecular Templates' float size? Molecular Templates currently has issued a total of 6,580,000 shares. Some of Molecular Templates' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Molecular Templates currently has a public float of 3,610,000 shares. How does Molecular Templates' short interest compare to its competitors? 4.68% of Molecular Templates' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Molecular Templates: Fortress Biotech, Inc. (12.69%), Alterity Therapeutics Limited (1.03%), NuCana plc (1.21%), Chemomab Therapeutics Ltd. (0.98%), Addex Therapeutics Ltd (1.85%), Galera Therapeutics, Inc. (7.34%), Aeterna Zentaris Inc. (0.34%), Guardion Health Sciences, Inc. (14.33%), Moleculin Biotech, Inc. (1.45%), MIRA Pharmaceuticals, Inc. (0.42%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Molecular Templates stock? Short selling MTEM is an investing strategy that aims to generate trading profit from Molecular Templates as its price is falling. MTEM shares are trading down $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Molecular Templates? A short squeeze for Molecular Templates occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of MTEM, which in turn drives the price of the stock up even further. How often is Molecular Templates' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MTEM, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Fortress Biotech Short Squeeze Alterity Therapeutics Short Squeeze NuCana Short Squeeze Chemomab Therapeutics Short Squeeze Addex Therapeutics Short Squeeze Galera Therapeutics Short Squeeze Aeterna Zentaris Short Squeeze Guardion Health Sciences Short Squeeze Moleculin Biotech Short Squeeze MIRA Pharmaceuticals Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:MTEM) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersShocking: One AI startup's revenue could surge 4,735%Manward PressThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaNext President (Not Trump. Not Biden.)The Freeport SocietyUrgent Nvidia WarningAltimetryElon’s New Device is About to Shock the WorldInvestorPlace"The Biggest Drug Ever" Is ComingBehind the MarketsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders